SCC
ORIAW

Spring Creek Capital’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Spring Creek Capital’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-160,000
Closed -$59K – 463
2022
Q1 		$59K Hold
160,000
– – ﹤0.01% 539
2021
Q4 		$154K Hold
160,000
– – 0.01% 432
2021
Q3 		$140K Buy
+160,000
New +$208K 0.01% 369

Other funds holding ORIAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Spring Creek Capital's ORIAW Position: Q2 2022 in Review

Spring Creek Capital sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2022, closing a stake of 160,000 shares — an estimated $59K sold.

Spring Creek Capital first reported a position in ORIAW in Q3 2021 and held it in 3 quarters. The position peaked at $154K in Q4 2021. 29 funds tracked by Wall St. Rank hold ORIAW as of Q2 2022.

  • Spring Creek Capital reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2022 after selling out during the quarter.
  • Spring Creek Capital sold 160,000 Orion Biotech Opportunities Corp. Warrant shares in Q2 2022, an estimated $59K.
  • Spring Creek Capital first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 3 quarters.
  • Spring Creek Capital's Orion Biotech Opportunities Corp. Warrant position peaked at $154K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.